Company spends 13.27 billion won to secure 39% stake, internalizing consumer goods capabilities
Full lineup of home-care devices and cosmetics set for launch next month
Major global marketing campaign, including top-tier brand ambassador, to follow
Wontech, a specialist in laser and energy-based medical solutions, is moving aggressively into the business-to-consumer market, using its flagship medical device brand Oligio as the vehicle for a full-scale expansion.
The company said Wednesday it would acquire a 39.03 percent treasury stake in Wonmedico — a home beauty device and cosmetics firm — for 13.27 billion won ($9.81 million). Wontech secured the funding through a 75 billion won strategic partnership it signed with private equity fund PACM in May, and the investment marks its formal push to build in-house consumer goods capabilities.
With the deal as a springboard, Wontech plans to leverage Oligio's intellectual property — previously confined to professional clinic equipment — to build what it calls an "Oligio Beauty Total Solution." The company intends to roll out a full product lineup spanning home-care devices and cosmetics, covering every stage of consumers' skincare routines beyond clinical procedures. New Oligio cosmetics products developed using Wonmedico's formulation expertise are set to launch sequentially starting next month.
Wontech also plans to step up investment to establish Oligio as a B2C brand, deploying a global top-tier ambassador and a large-scale marketing campaign to broaden the brand's reach into the mass market. Alongside this, the company will defend its share in the clinical segment with the next-generation flagship device Oligio xm, which combines radiofrequency and high-intensity focused ultrasound energy in a single platform.
The moves reflect a strategic effort to transfer the brand credibility Wontech has built through its high-margin B2B medical device business into the consumer goods space, with the goal of creating a comprehensive beauty and healthcare ecosystem anchored by the single Oligio IP.
"We will connect consumers' entire beauty journey — from clinical procedures to skincare — under one Oligio universe," a Wontech official said. "We will back that with significant marketing investment and develop the B2C market into our next core growth engine."
silverpaper@heraldcorp.com